PCG
GILD icon

Prosperity Consulting Group’s Gilead Sciences GILD Stock Holding History

Prosperity Consulting Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Sell
26,812
-829
-3% -$109K 0.13% 120
2026
Q1 		$3.85M Sell
27,641
-1,525
-5% -$214K 0.17% 96
2025
Q4 		$3.58M Buy
29,166
+321
+1% +$39K 0.16% 102
2025
Q3 		$3.2M Sell
28,845
-559
-2% -$63.5K 0.16% 113
2025
Q2 		$3.26M Buy
29,404
+4,107
+16% +$437K 0.24% 98
2025
Q1 		$2.83M Sell
25,297
-1,500
-6% -$155K 0.22% 105
2024
Q4 		$2.48M Sell
26,797
-1,767
-6% -$159K 0.19% 124
2024
Q3 		$2.39M Sell
28,564
-7,806
-21% -$596K 0.19% 127
2024
Q2 		$2.5M Sell
36,370
-16,615
-31% -$1.11M 0.34% 76
2024
Q1 		$3.88M Buy
52,985
+48,832
+1,176% +$3.76M 0.49% 58
2023
Q4 		$336K Buy
+4,153
New +$323K 0.11% 151

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prosperity Consulting Group's GILD Position: Q2 2026 in Review

Prosperity Consulting Group reduced its Gilead Sciences (GILD) stake by 3% in Q2 2026, selling an estimated $109K and leaving 26,812 shares worth $3.39M. The position accounts for 0.13% of the portfolio, ranked #120.

Prosperity Consulting Group first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.88M in Q1 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Prosperity Consulting Group held 26,812 shares of Gilead Sciences worth $3.39M as of Q2 2026.
  • Prosperity Consulting Group sold 829 Gilead Sciences shares in Q2 2026, an estimated $109K.
  • Gilead Sciences made up 0.13% of Prosperity Consulting Group's portfolio in Q2 2026, its #120 holding.
  • Prosperity Consulting Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Prosperity Consulting Group's Gilead Sciences position peaked at $3.88M in Q1 2024.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.